Not recruitingEUCTR 2021-003600-41
AMIloride for the treatment of Nephrogenic Diabetes insipidus for patients with Bipolarity treated with lithium: a randomized controlled trial
This historical record does not confirm current site availability.
Historical research recordAges 18–70France
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Who could participate?
The CTIS protocol lists adults aged 18 to under 70 living with bipolarity who have taken lithium for at least five years and have impaired urine concentration.
What does the protocol involve?
The trial examined whether amiloride improved urine concentration after two months of treatment.
- Listed locations
- Colombes Cedex and 6 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This is historical registry information. What is the current study status and protocol?
Things to check before joining
Study start dateStarted: January 11, 2023
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Assistance Publique – Hôpitaux de Paris (AP-HP)
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- France
- Age range
- From 18 Years to 70 Years
- Official registry ID
- EUCTR 2021-003600-41
- Official title
Show the full official title
AMIloride for the treatment of Nephrogenic Diabetes insipidus for patients with bipolar disorder treated with lithium: a randomized controlled trial
Recruitment & locations
Not recruitingColombes Cedex · Creteil · Creteil Cedex
2 more locations
- Paris
- Paris Cedex 18
Next step · Check the official record for the status. You can also look for open studies on HopeStage.
Registry details
Original registry record (opens in a new tab)Current country statuses
- France — Ended
Historical country statuses
- France — Trial now transitioned
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Assistance Publique – Hôpitaux de Paris (AP-HP).
Does this study involve medication?
Yes. The study involves medication, including Anhydrous Amiloride Hydrochloride and Placebo.
Who could participate?
The CTIS protocol lists adults aged 18 to under 70 living with bipolarity who have taken lithium for at least five years and have impaired urine concentration.
Is this study still recruiting?
The registry lists this study as not recruiting.
Want to explore more studies?
Explore studiesRelated studies
A 6-Month, Open-Label, Flexible-Dosage (150 to 200 mg/day) Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With ...
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY, COMPARING THE EFFICACY AND TOLERABILITY OF ZIPRASIDONE (ZELDOX®, GEODON®) VS OLANZAPINE (ZYPREXA®) IN THE TREATMENT AND MAINTENANCE OF...